Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus

This publication has 25 references indexed in Scilit:

• Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins
  Clinical and Vaccine Immunology, 2007
• Preconceptual Administration of an Alphavirus Replicon UL83 (pp65 Homolog) Vaccine Induces Humoral and Cellular Immunity and Improves Pregnancy Outcome in the Guinea Pig Model of Congenital Cytomegalovirus Infection
  The Journal of Infectious Diseases, 2007
• Alphavirus replicon approach to promoterless analysis of IRES elements
  Virology, 2006
• Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee
  Clinical Infectious Diseases, 2004
• Clinical aspects of cmv infection after stem cell transplantation
  Human Immunology, 2004
• Is there a formula for an effective CMV vaccine?
  Journal of Clinical Virology, 2002
• Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV‐Seronegative Adults
  The Journal of Infectious Diseases, 2002
• A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative Subjects
  The Journal of Infectious Diseases, 2001
• A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant
  The Journal of Infectious Diseases, 1999
• DEVELOPMENT OF A VACCINE AGAINST MENTAL RETARDATION CAUSED BY CYTOMEGALOVIRUS INFECTION IN UTERO
  The Lancet, 1974